Tanvex BioPharma Enters Exclusive Distribution Agreement for Nypozi (filgrastim) in Canada May.16,2023 Oct.04,2021 FDA Accepts TX05 BLA Filing Read More Jun.20,2021 Tanvex entering into service contract with OBI Read More Oct.17,2021 Tanvex received marketing authorization from Health Canada Read More